Your child’s care will vary depending on the specific type of thyroid cancer they have. Components of thyroid cancer treatment may include the following.
Surgery is the first and most important treatment for thyroid cancer. Thoroughly and safely removing as much of the tumor as possible is important to ensure the best possible long-term outcome. This often includes removing the entire thyroid gland, and if necessary any lymph nodes in the neck that may contain thyroid cancer. This allows your doctors to form a complete diagnosis of the cancer type and obtain information on the stage of the disease, which will help determine if any further treatments are necessary.
Thyroid surgery is generally safe but rarely can have serious complications. For this reason, it is important that the procedure be performed by an experienced thyroid surgeon. Our thyroid surgeons have extensive experience in pediatric thyroid surgery and work closely with the rest of the Thyroid Center team to provide seamless, coordinated care before, during, and after surgery.
Radioactive iodine therapy may be recommended to destroy any remaining cancer cells after surgery. This therapy uses the natural need of thyroid cells for iodine to treat thyroid cancer cells that may remain in the body after surgery. Radioactive iodine is absorbed by and destroys these remaining thyroid cells, even if they are located in areas that cannot be removed by surgery (like the lungs). In patients with high-risk thyroid cancer, radioactive iodine therapy can improve outcomes and reduce the risk of thyroid cancer recurrence. Radioactive iodine can only be used to treat differentiated types of thyroid cancers, not medullary thyroid cancers.
Hormone therapy is used to replace normal hormones and slow the growth of cancer cells. If the entire thyroid was removed, lifelong treatment with thyroid medication is needed. In patients with high-risk thyroid cancer, giving a slight excess of thyroid medication may improve outcomes and reduce the risk of thyroid cancer recurrence.
Molecular therapies may be effective for patients with advanced differentiated thyroid carcinoma that does not respond to surgery and radioactive iodine therapy, and for patients with advanced medullary thyroid carcinoma. Many of these new, experimental therapies are available in our Thyroid Center as part of research trials.